A case of hyperparathyroidism-jaw tumour syndrome found in the treatment of an ossifying fibroma in the maxillary bone

International Journal of Oral and Maxillofacial Surgery

Volumn 36, Issue 4, 2007, Pages 365-369

  Yamashita, Y ^a   Akiyama, T ^a   Mizusawa, N ^b   Yoshimoto, K ^b   Goto, M ^a  

^a SAGA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PARAFIBROMIN; TECHNETIUM 99M; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE BIOPSY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DENTAL CARIES; ECHOGRAPHY; FOLLOW UP; GENE DELETION; GENE MUTATION; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPERPARATHYROIDISM JAW TUMOR SYNDROME; JAW TUMOR; MALE; MAXILLA RESECTION; MAXILLA TUMOR; OSSIFYING FIBROMA; PARATHYROID ADENOMA; PARATHYROIDECTOMY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIMARY HYPERPARATHYROIDISM; TUMOR RECURRENCE;

ADENOMA; ADOLESCENT; DIAGNOSIS, DIFFERENTIAL; FIBROMA, OSSIFYING; FOLLOW-UP STUDIES; GENE DELETION; GERM-LINE MUTATION; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MAXILLARY NEOPLASMS; PARATHYROID NEOPLASMS; SYNDROME; TOMOGRAPHY, X-RAY COMPUTED; TUMOR SUPPRESSOR PROTEINS;

EID: 33847053143     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijom.2006.08.007     Document Type: Article

References (20)

1. Aldred M.J., Talacko A.A., Savarirayan R., Murdolo V., Mills A.E., Radden B.G., Alimov A., Villablanca A., and Larsson C. Dental findings in a family with hyperparathyroidism-jaw tumor syndrome and a novel HRPT2 gene mutation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101 (2006) 212-218
2. Carpten J.D., Robbins C.M., Villablanca A., Forsberg L., Presciuttini S., Bailey-Wilson J., Simonds W.F., Gillanders E.M., Kennedy A.M., Chen J.D., Agarwal S.K., Sood R., Jones M.P., Moses T.Y., Haven C., Petillo D., Leotlela P.D., Harding B., Cameron D., Pannett A.A., Hoog A., Heath III H., James-Newton L.A., Robinson B., Zarbo R.J., Cavaco B.M., Wassif W., Perrier N.D., Rosen I.B., Kristoffersson U., Turnpenny P.D., Farnebo L.O., Besser G.M., Jackson C.E., Morreau H., Trent J.M., Thakker R.V., Marx S.J., Teh B.T., Larsson C., Hobbs M.R., and HRPT2. encoding parafibromin, is mutated in hyperparathyroidism-jaw tumors syndrome. Nat Genet 32 (2002) 676-680
3. Cavaco B.M., Barros L., Pannett A.A., Ruas L., Carvalheiro M., Ruas M.M., Krausz T., Santos M.A., Sobrinho L.G., Leite V., and Thakker R.V. The hyperparathyroidism-jaw tumour syndrome in a Portuguese kindred. QJM 94 (2001) 213-222
4. Cavaco B.M., Guerra L., Bradley K.J., Carvalho D., Harding B., Oliveira A., Santos M.A., Sobrinho L.G., Thakker R.V., and Leite V. Hyperparathyroidism-jaw tumor syndrome in Roma families from Portugal is due to a founder mutation of the HRPT2 gene. J Clin Endocrinol Metab 89 (2004) 1747-1752
5. Cetani F., Pardi E., Borsari S., Viacava P., Dipollina G., Cianferotti L., Ambrogini E., Gazzerro E., Colussi G., Berti P., Miccoli P., Pinchera A., and Marcocci C. Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: Germline and somatic mutations in familial and sporadic parathyroid tumors. J Clin Endocrinol Metab 89 (2004) 5583-5591
6. Chen J.D., Morrison C., Zhang C., Kahnoski K., Carpten J.D., and Teh B.T. Hyperparathyroidism-jaw tumour syndrome. J Intern Med 253 (2003) 634-642
7. Haven C.J., Wong F.K., van Dam E.W., van der Juijt R., van Asperen C., Jansen J., Rosenberg C., de Wit M., Roijers J., Hoppener J., Lips C.J., Larsson C., Teh B.T., and Morreau H. A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumour syndrome. J Clin Endocrinol Metab 85 (2000) 1449-1454
8. Howell V.M., Haven C.J., Kahnoski K., Khoo S.K., Petillo D., Chen J., Fleuren G.J., Robinson B.G., Delbridge L.W., Philips J., Nelson A.E., Krause U., Hammje K., Dralle H., Hoang-Vu C., Gimm O., Marsh D.J., Morreau H., and Teh B.T. HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J Med Genet 40 (2003) 657-663
9. Jackson C.E., Norum R.A., Boyd S.B., Talpos G.B., Wilson S.D., Taggart R.T., and Mallette L.E. Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: a clinically and genetically distinct syndrome. Surgery 108 (1990) 1006-1013
10. Marx S.J. Hyperparathyroidism and hypoparathyroid disorders. N Engl J Med 343 (2000) 1863-1875
11. Moon S.D., Park J.H., Kim E.M., Kim J.H., Han J.H., Yoo S.J., Yoon K.H., Kang M.I., Lee K.W., Son H.Y., Kang S.K., Oh S.J., Kim K.M., Yoon S.J., Park J.G., Kim I.J., Kang H.C., Hong S.W., Kim K.R., and Cha B.Y. A Novel IVS2-1G>A mutation causes aberrant splicing of the HRPT2 gene in a family with hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab 90 (2005) 878-883
12. Pimenta F.J., Gontijo Silveira L.F., Tavares G.C., Silva A.C., Perdigao P.F., Castro W.H., Gomez M.V., Teh B.T., De Marco L., and Gomez R.S. HRPT2 gene alterations in ossifying fibroma of the jaws. Oral Oncol 42 (2006) 735-739
13. Rozenblatt-Rosen O., Hughes C.M., Nannepaga S.J., Shanmugam K.S., Copelamd T.D., Guszczynski T., Resau J.H., and Meyerson M. The parafibromin tumor suppressor protein is part of a human Paf1 complex. Mol Cell Biol 25 (2005) 612-620
14. Shattuck T.M., Valimaki S., Obara T., Gaz R.D., Clark O.H., Shoback D., Wierman M.E., Tojo K., Robbins C.M., Carpten J.D., Farnebo L.O., Larsson C., and Arnold A. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 349 (2003) 1722-1729
15. Simonds W.F., Robbins C.M., Agarwal S.K., Hendy G.N., Carpten J.D., and Marx S.J. Familial isolated hyperparathyroidism is rarely caused by germ-line mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab 89 (2004) 96-102
16. Slootweg P.J., and EI Mofty S.K. Pathology and genetics of the head and neck tumours. In: Barnes L., Eveson J.W., Reichart P., and Sidransky D. (Eds). World Health Organization Classification of Tumours (2005), IARC Press, Lyon 319-320
17. Szabo J., Heath B., Hill V.M., Jackson C.E., Zarbo R.J., Mallette L.E., Chew S.L., Besser G.M., Thakker R.V., Huff V., Leppert M.F., and Heath III H. Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. Am J Hum Genet 56 (1995) 944-950
18. Villablanca A., Calender A., Forsberg L., Hoog A., Cheng J.D., Petillo D., Bauters C., Kahnoski K., Ebeling T., Salmela P., Richardson A.L., Delbridge L., Meyrier A., Proye C., Carpten J.D., Teh B.T., Robinson B.G., and Larsson C. Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP). J Med Genet 41 (2004) e32
19. Woodard G.E., Lin L., Zhang J.H., Agarwal S.K., Mark S.J., and Simonds W.F. Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression. Oncogene 24 (2005) 1272-1276
20. Yart A., Gstaiger M., Wirbelauer C., Pecnik M., Anastasiou D., Hess D., and Krek W. The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II. Mol Cell Biol 25 (2005) 5052-5060